ECMO saves 71-year-old doctor from unusual presentation of ARDS in a malaria case
KOLKATA: In an uncommon case a 71-year-old had developed severe respiratory distress syndrome (ARDS) after he tested positive ...
Medscape7d
Methylprednisolone Infusion in Early Severe ARDS - Results of a Randomized Controlled Trial
This is the first randomized controlled trial investigating the efficacy and safety of low-dose prolonged methylprednisolone administration in early ARDS. This study tested a pathophysiologic ...
Nature8mon
Targeting vascular dysfunction to help the body battle disease
It has a high risk of long-term damage and death; mortality is 32–45% in patients with moderate-to-severe ARDS. “In ARDS, the membranes become ‘leaky’—this means that patients have ...
BGR7d
Think coronavirus is no worse than the flu? You need to read this
They also had worse lung function and were more likely to develop severe lung inflammation. “The finding that ARDS (acute respiratory distress syndrome) may be more prevalent among critically ...
News Medical on MSN3d
Phase 2 study evaluates safety and efficacy of asunercept in COVID-19 patients
The ASUNCTIS trial evaluated asunercept's safety and efficacy in COVID-19, showing trends toward faster recovery despite not ...
Medscape1mon
Methylprednisolone Infusion in Early Severe ARDS - Results of a Randomized Controlled Trial
Objective: To determine the effects of low-dose prolonged methylprednisolone infusion on lung function in patients with early severe ARDS. Design: Randomized, double-blind, placebo-controlled trial.